Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Other Operating Expenses (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Other Operating Expenses for 13 consecutive years, with $2.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Operating Expenses rose 29.72% to $2.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.2 million, a 2.11% decrease, with the full-year FY2025 number at $7.2 million, down 2.11% from a year prior.
  • Other Operating Expenses was $2.4 million for Q4 2025 at Ekso Bionics Holdings, up from $1.3 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $2.4 million in Q4 2025 to a low of $1.3 million in Q3 2025.
  • A 5-year average of $1.9 million and a median of $1.8 million in 2021 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: dropped 28.85% in 2021, then surged 31.01% in 2023.
  • Ekso Bionics Holdings' Other Operating Expenses stood at $2.0 million in 2021, then fell by 4.66% to $1.9 million in 2022, then rose by 1.95% to $2.0 million in 2023, then dropped by 4.99% to $1.9 million in 2024, then rose by 29.72% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Other Operating Expenses are $2.4 million (Q4 2025), $1.3 million (Q3 2025), and $1.7 million (Q2 2025).